Emerald Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$931K Buy
3,808
+3
+0.1% +$699 0.12% 56
2025
Q4
$787K Buy
3,805
+291
+8% +$57.5K 0.11% 62
2025
Q3
$652K Buy
3,514
+154
+5% +$26.4K 0.09% 64
2025
Q2
$513K Sell
3,360
-189
-5% -$29.1K 0.07% 69
2025
Q1
$589K Buy
3,549
+458
+15% +$71.7K 0.08% 59
2024
Q4
$447K Buy
3,091
+75
+2% +$11.6K 0.06% 66
2024
Q3
$498K Sell
3,016
-11
-0.4% -$1.75K 0.07% 63
2024
Q2
$442K Sell
3,027
-114
-4% -$17K 0.07% 64
2024
Q1
$497K Sell
3,141
-140
-4% -$22.3K 0.09% 58
2023
Q4
$514K Buy
3,281
+83
+3% +$12.7K 0.1% 52
2023
Q3
$498K Sell
3,198
-29
-0.9% -$4.79K 0.12% 48
2023
Q2
$534K Buy
3,227
+111
+4% +$17.9K 0.13% 47
2023
Q1
$483K Buy
3,116
+12
+0.4% +$1.94K 0.12% 47
2022
Q4
$548K Buy
3,104
+88
+3% +$15.2K 0.15% 43
2022
Q3
$493K Buy
3,016
+57
+2% +$9.65K 0.14% 47
2022
Q2
$525K Buy
2,959
+46
+2% +$8.2K 0.15% 45
2022
Q1
$516K Buy
2,913
+92
+3% +$15.7K 0.12% 53
2021
Q4
$483K Buy
+2,821
New +$462K 0.12% 56
2020
Q1
Sell
-3,498
Closed -$520K 93
2019
Q4
$520K Buy
+3,498
New +$474K 0.5% 31

Other funds holding JNJ

Emerald Advisors's JNJ Position: Q1 2026 in Review

Emerald Advisors increased its Johnson & Johnson (JNJ) stake by 0.08% in Q1 2026, buying an estimated $699 and bringing the position to 3,808 shares worth $931K. The position accounts for 0.12% of the portfolio, ranked #56.

Emerald Advisors first reported a position in JNJ in Q4 2019 and has held it in 19 quarters since. 4,613 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Emerald Advisors held 3,808 shares of Johnson & Johnson worth $931K as of Q1 2026.
  • Emerald Advisors bought 3 Johnson & Johnson shares in Q1 2026, an estimated $699.
  • Johnson & Johnson made up 0.12% of Emerald Advisors's portfolio in Q1 2026, its #56 holding.
  • Emerald Advisors first reported a position in Johnson & Johnson in Q4 2019 and has held it in 19 quarters since.
  • 4,613 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Emerald Advisors's 13F filing for Q1 2026, filed 24 Apr 2026.